CELG-RI Bristol-Myers Squibb Company Ce
0.1248USD+5.05%Mkt Cap: —P/E: —6d ago
Industry Peers
Drug Manufacturers - General$1.06TUSDP/E 39.9
LLY
Eli Lilly and Company$1.01TUSDP/E 39.6
$622.84BUSDP/E 29.9
$479.52BUSDP/E 76.7
ABBV
AbbVie Inc.$458.43BUSDP/E 76.9
$335.37BUSDP/E 24.1
$352.29BUSDP/E 113.3
ROP
Roche Holding AG$327.37BUSDP/E 23.5
MRK
Merck & Co., Inc.$351.41BUSDP/E 112.9
ROG
Roche Holding AG$331.80BUSDP/E 21.4
$260.36BUSDP/E 22.9
$272.33BUSDP/E 21.6
$260.71BUSDP/E 25.2
NVS
Novartis AG$266.84BUSDP/E 22.5
$238.84BUSDP/E 25.7
$248.33BUSDP/E 23.9
$223.32BUSDP/E 25.7
$205.33BUSDP/E 24.4
AMGN
Amgen Inc.$217.60BUSDP/E 25.6
$182.09BUSD
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)—
Revenue/Share—
Last Price0.1248 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B—
EPS (TTM)—
EPS (Forward)—
52W Range
0.080049% of range0.1710
52W High0.1710 USD
52W Low0.0800 USD
Profitability
Gross Margin—
Oper. Margin—
EBITDA Margin—
Profit Margin—
ROE—
ROA—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio—
Quick Ratio—
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate—
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateMar 11, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float—
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta—
S&P 52W Chg—
Avg Vol (30d)12.45K
Avg Vol (10d)—
Technical Indicators
RSI (14)55.9
MACD0.0030
MACD Signal0.0027
MACD Hist.+0.0003
BB Upper0.1461 USD
BB Middle0.1172 USD
BB Lower0.0883 USD
BB Width49.39%
ATR (14)0.0159 USD
Vol Ratio (20d)0.35x